Skip to content
Katsuyuki Takeda

Katsuyuki Takeda, MD, is a researcher at National Jewish Health. Dr. Takeda is in the Division of Cell Biology and Department of Pediatrics.

Special Interests

Research Interests

Bronchial asthma; as asthma is the most common chronic inflammatory lung disease, I intend to elucidate the disease mechanisms and explore a new therapeutic approach.

Emphysema; as emphysema is a terminal stage of lung damage in lung diseases such as cigarette smoking-associated COPD or Alpha 1-antitrypsin deficiency, which is a genetic disease. My goal is to explore a novel therapeutic tool to repair and normalize damaged lung tissue.



Okayama Medical School, PhD
Tottori University, MD

Awards & Recognition

1998: Astra Research Grant (Competitive Grant for Asthma Research, Japan)
2010: ATS Grant “Alpha-1 Foundation Research Grant in Alpha-1”

Board Certification

Japanese Society of Internal Medicine 

Professional Memberships

American Thoracic Society (ATS)
Japanese Society of Internal Medicine


Takeda K, et al. Immunomodulatory Effects of Ambroxol on Airway Hyperresponsiveness and Inflammation. Immune Netw. 2016;16:165-75.

Takeda K, et al. Eosinophils contribute to the resolution of lung-allergic responses following repeated allergen challenge. J Allergy Clin Immunol. 2015;135:451-460.

Takeda K, et al. The Critical Role of Complement Alternative Pathway Regulator Factor H in Allergen-Induced Airway Hyperresponsiveness and Inflammation. J Immunol. 2012 188:661-7. 9.     

Takeda K, et al. Effects of combination therapy with montelukast and carbocysteine in allergen-induced airway hyperresponsiveness and airway inflammation. Br J Pharmacol, 2010, 160:1399-407. 14. 

Takeda K, et al. Vaccine-Induced CD8  T Cell-Dependent Suppression of Airway Hyperresponsiveness and Inflammation. J Immunol. 2009, 183:181-90.

Website Information

Takeda Lab